NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

This is unfortunately not going anywhere until they bring a big pharma partner on board. MIA will definitely be perceived as meh unless it’s accompanied by some other surprise such as FDA BLA news or UK regulatory approval coupled with an update on NICE timing.

Until then we will continue to get diluted at .60s.

Why they didn’t use CRL or other CDMO in UK to get MHRA approvals last year is beyond me! This way, they wouldn’t have had to wait for Advent to catch up with commercial certifications. They could have also made progress with FDA BLA application and could have gotten BLA accepted last year with CRL as a manufacturing partner.